Repeated doses of Praziquantel in Schistosomiasis Treatment (RePST) – single versus multiple praziquantel treatments in school-aged children in Côte d’Ivoire: a study protocol for an open-label, randomised controlled trial

BACKGROUND: Large scale administration of the anthelminthic drug praziquantel (PZQ) to at-risk populations is the cornerstone of schistosomiasis control, although persisting high prevalence of infections in some areas and growing concerns of PZQ resistance have revealed the limitations of this strat...

Descripción completa

Detalles Bibliográficos
Autores principales: Hoekstra, P. T., Casacuberta Partal, M., Amoah, A. S., van Lieshout, L., Corstjens, P. L. A. M., Tsonaka, S., Assaré, R. K., Silué, K. D., Meité, A., N’Goran, E. K., N’Gbesso, Y. K., Roestenberg, M., Knopp, S., Utzinger, J., Coulibaly, J. T., van Dam, G. J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6295059/
https://www.ncbi.nlm.nih.gov/pubmed/30547750
http://dx.doi.org/10.1186/s12879-018-3554-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6295059/
https://www.ncbi.nlm.nih.gov/pubmed/30547750
http://dx.doi.org/10.1186/s12879-018-3554-2

Ejemplares similares